BridgeBio
Focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. Learn more
Launch date
Employees
Market cap
AUD7.6b
Enterprise valuation
AUD9.6b (Public information from Sep 2024)
Share price
$26.83 BBIO
Palo Alto California (HQ)
Authorizing premium user...